2013
DOI: 10.1182/blood-2012-09-456079
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis

Abstract: Key Points• The study establishes a reliable method to quantify differentiating mouse erythroblasts and to monitor terminal mouse erythropoiesis in vivo.• Quantitative analysis of erythropoiesis of thalassemia mice revealed stage-specific changes in terminal erythroid differentiation.Terminal erythroid differentiation is the process during which proerythroblasts differentiate to produce enucleated reticulocytes. Although it is well established that during murine erythropoiesis in vivo, 1 proerythroblast underg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

8
211
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 193 publications
(220 citation statements)
references
References 31 publications
8
211
0
1
Order By: Relevance
“…No significant changes were observed with CD71/Ter119 staining in conditional mutant mice (Fig 2F). Apart from subtle increases in fraction II of Epor-Cre Rara fl/fl g fl/fl mice and reductions in fraction V of Epor-Cre Rara fl/fl mice (Fig 2G), analysis using CD44 and Ter119 expression supported the conclusion that there was no major changes in erythroid populations (Liu et al, 2013). The CFU-E, PreCFU-E and megakaryocyte-erythroid phenotypic fractions did not differ significantly from the control mice (Fig 2H).…”
supporting
confidence: 51%
See 1 more Smart Citation
“…No significant changes were observed with CD71/Ter119 staining in conditional mutant mice (Fig 2F). Apart from subtle increases in fraction II of Epor-Cre Rara fl/fl g fl/fl mice and reductions in fraction V of Epor-Cre Rara fl/fl mice (Fig 2G), analysis using CD44 and Ter119 expression supported the conclusion that there was no major changes in erythroid populations (Liu et al, 2013). The CFU-E, PreCFU-E and megakaryocyte-erythroid phenotypic fractions did not differ significantly from the control mice (Fig 2H).…”
supporting
confidence: 51%
“…There were profound reductions in Ter119 + CD71 hi and Ter119 + CD71 med fractions in the BM of RARc À/À mice (Fig 1A-B) indicating reduced immature erythroblasts at the pro-erythroblast stage, similarly evident using CD44 and Ter119 staining (Fig 1C-D) (Liu et al, 2013). Analysis of the erythroid progenitor fractions (Pronk & Bryder, 2010) showed a reduction in the megakaryocyteerythroid progenitor fraction ( Fig 1E) with a concomitant increase in megakaryocyte-committed progenitors (Fig 1F) and a significant reduction in the erythroid colony-forming unit (CFU-E) fraction (Fig 1G).…”
mentioning
confidence: 75%
“…A 4 day G-CSF treatment, which mobilizes HSC into the blood, reduced the number of according to decreasing CD44 expression and forward scatter [25,26]. This staining and gating strategy confirmed the marked reduction in all differentiation stages of erythroblasts, In order to determine whether the effect of G-CSF on macrophages was directly mediated via the G-CSF receptor, we sorted from the BM of untreated mice F4/80 + VCAM- showed that G-CSF receptor mRNA (Csf3r) was abundantly expressed by these macrophages, whereas it was absent in IgM + and IgM -B cells (Fig.…”
Section: G-csf Treatment Causes Bm Anemiamentioning
confidence: 99%
“…(C-F) Flow cytometric analysis of CD44 and forward scatter levels of CD45 negative erythroblasts from the bone marrow (C) and spleen (E) of indicated mice. Populations I-VI were defined as proerythroblasts, basophilic erythroblasts, polychromatic erythroblasts, orthochromatic erythroblasts, reticulocytes, and red blood cells, respectively 9 . Statistical analysis of (C) and (E) were shown in (D) and (F), respectively.…”
mentioning
confidence: 99%